Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Fuzheng Injection for cancer-related fatigue and radiation pneumonitis in advanced NSCLC patients undergoing radiotherapy
ChiCTR2300068524Phase 4Not yet recruiting
- Sponsor
- Huaihe Hospital of Henan University
- Start
- Feb 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of shenqi fuzheng injection in non-small cell lung cancer (NSCLC), cancer-related fatigue (CRF) and radiation pneumonitis (RP) (2 arms), sponsored by Huaihe Hospital of Henan University. Primary endpoints: Revised Piper Fatigue Scale and Scale of symptoms of primary lung cancer. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
shenqi fuzheng injection
03
Conditions
non-small cell lung cancer (NSCLC)cancer-related fatigue (CRF)radiation pneumonitis (RP)
Beyond the preview
Go deeper on ChiCTR2300068524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068524.